Literature DB >> 15206530

Multiple testing of noninferiority hypotheses in active controlled trials.

H M James Hung1, Sue-Jane Wang.   

Abstract

For noninferiority testing with the maximum allowable noninferiority margin being prespecified, one can perform valid statistical testing at the same alpha level for multiple noninferiority hypotheses with margins being smaller than this maximum margin. This is easily comprehensible because only one confidence level is used to assess which margins within the interval bounded by the maximum margin can be ruled out. If different confidence intervals are used, e.g., the interval generated from the intent-to-treat population is used for testing superiority and the interval generated from the per-protocol population is used for testing noninferiority, the problem of multiplicity will surface and the adjustment of alpha for each testing may be needed. All these predicate on the condition that at least a certain element of the maximum allowable noninferiority margin, whether it is the entire margin or the fraction of the active control effect to be retained, must be fixed in advance. None of these elements can be allowed to be influenced directly or indirectly by any analysis of the noninferiority trial data. Otherwise, the noninferiority analysis may be invalid.

Mesh:

Year:  2004        PMID: 15206530     DOI: 10.1081/BIP-120037183

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  3 in total

1.  Non-inferiority Testing for Risk Ratio, Odds Ratio and Number Needed to Treat in Three-arm Trial.

Authors:  Shrabanti Chowdhury; Ram C Tiwari; Samiran Ghosh
Journal:  Comput Stat Data Anal       Date:  2018-09-15       Impact factor: 1.681

2.  Bayesian Approach for Assessing Non-inferiority in Three-arm Trials for Risk Ratio and Odds Ratio.

Authors:  Shrabanti Chowdhury; Ram C Tiwari; Samiran Ghosh
Journal:  Stat Biopharm Res       Date:  2019-04-22       Impact factor: 1.452

3.  New approaches for testing non-inferiority for three-arm trials with Poisson distributed outcomes.

Authors:  Samiran Ghosh; Erina Paul; Shrabanti Chowdhury; Ram C Tiwari
Journal:  Biostatistics       Date:  2022-01-13       Impact factor: 5.899

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.